2014 Annual Report
Message from the CEO
Message from the CEO

Tuberculosis remains one of the world's leading global health threats, killing more than 4,000 people each day. Today's treatments cannot most effectively combat the pandemic because they are too long and complex, and poorly effective against drug-resistant TB.

TB Alliance's ultimate vision is to have a transformative impact on the disease by introducing an ultra-short, simple, and affordable TB regimen that works in virtually all people with tuberculosis. A multi-drug regimen with such broad utility would have a major impact on the global epidemic, saving millions of lives.

To achieve this impact, new regimens must be Adopted, Available, and Affordable.

To read more about out AAA Mandate, click here.

Today's treatment for active TB must be taken for 6 months to 2 years, or more. Our vision is to treat a vast majority of patients with active TB with a single shorter, simpler, and more affordable regimen, and save millions of lives.
Back To Top
Our Vision: Short, Simple, Affordable Treatment for All
Clinical Research Paves Way for New Products
Reaching Children
Breakthroughs in Drug Discovery
Strong Partners, Empowered Communities